(Q38375202)

2 September 2017

1 reference

title

Renin-angiotensin system: an old player with novel functions in skeletal muscle (English)

1 reference

2 September 2017

author name string

Claudio Cabello-Verrugio

1

1 reference

2 September 2017

María Gabriela Morales

2

1 reference

2 September 2017

Juan Carlos Rivera

3

1 reference

2 September 2017

Daniel Cabrera

4

1 reference

2 September 2017

Felipe Simon

5

1 reference

2 September 2017

publication date

11 March 2015

1 reference

Medicinal Research Reviews

2 September 2017

published in

1 reference

2 September 2017

volume

35

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

437-463

1 reference

Physiology of local renin-angiotensin systems.

2 September 2017

cites work

1 reference

Disappearance of angiotensin from the circulation of the dog.

21 January 2018

1 reference

Renin-angiotensin system in the pathogenesis of liver fibrosis

21 January 2018

1 reference

Inhibition of the renin angiotensin system: implications for the endothelium

21 January 2018

1 reference

Angiotensin II: role in skeletal muscle atrophy

21 January 2018

1 reference

Skeletal muscle myoblasts possess a stretch-responsive local angiotensin signalling system

21 January 2018

1 reference

Variation in ACE activity affects myogenic differentiation in C2C12 cells

21 January 2018

1 reference

Characterization of angiotensin-converting enzymes 1 and 2 in the soleus and plantaris muscles of rats.

21 January 2018

1 reference

The ACE gene and human performance: 12 years on.

21 January 2018

1 reference

Skeletal muscle RAS and exercise performance

21 January 2018

1 reference

The angiotensin converting enzyme insertion/deletion polymorphism alters the response of muscle energy supply lines to exercise

21 January 2018

1 reference

Decreased muscle ACE activity enhances functional response to endurance training in rats, without change in muscle oxidative capacity or contractile phenotype.

21 January 2018

1 reference

Intramuscular renin-angiotensin system is activated in human muscular dystrophy.

21 January 2018

1 reference

Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice

21 January 2018

1 reference

Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).

21 January 2018

1 reference

Recent progress in molecular mechanisms of angiotensin II type 1 and 2 receptors

21 January 2018

1 reference

IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting

21 January 2018

1 reference

Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.

21 January 2018

1 reference

Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling

21 January 2018

1 reference

Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.

21 January 2018

1 reference

Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.

21 January 2018

1 reference

Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states

21 January 2018

1 reference

Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration

21 January 2018

1 reference

Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis

21 January 2018

1 reference

Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors

21 January 2018

1 reference

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.

21 January 2018

1 reference

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.

21 January 2018

1 reference

Angiotensin-converting enzyme 2: the first decade

21 January 2018

1 reference

Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice

21 January 2018

1 reference

Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.

21 January 2018

1 reference

Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo

21 January 2018

1 reference

ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.

21 January 2018

1 reference

Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice

21 January 2018

1 reference

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

Kininase II-type enzymes. Their putative role in muscle energy metabolism

21 January 2018

1 reference

Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis.

21 January 2018

1 reference

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

Mas oncogene signaling and transformation require the small GTP-binding protein Rac

21 January 2018

1 reference

Parental imprinting of the Mas protooncogene in mouse

21 January 2018

1 reference

Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues

21 January 2018

1 reference

Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas.

21 January 2018

1 reference

Expression of the Mas receptor is upregulated in skeletal muscle wasting.

21 January 2018

1 reference

ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle.

21 January 2018

1 reference

The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.

21 January 2018

1 reference

Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling

21 January 2018

1 reference

Developmentally spliced PKCbetaII provides a possible link between mTORC2 and Akt kinase to regulate 3T3-L1 adipocyte insulin-stimulated glucose transport

21 January 2018

1 reference

Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation

21 January 2018

1 reference

Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport.

21 January 2018

1 reference

The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle

21 January 2018

1 reference

Insulin resistance: definition and consequences

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts

21 January 2018

1 reference

New therapeutic pathways in the RAS.

21 January 2018

1 reference

Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans

21 January 2018

1 reference

Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension

21 January 2018

1 reference

Oxidative stress and the etiology of insulin resistance and type 2 diabetes

21 January 2018

1 reference

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

21 January 2018

1 reference

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

Cross-talk between the insulin and angiotensin signaling systems

21 January 2018

1 reference

Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells.

21 January 2018

1 reference

Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase

21 January 2018

1 reference

Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms

21 January 2018

1 reference

Direct inhibition by angiotensin II of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism

21 January 2018

1 reference

Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK.

21 January 2018

1 reference

Contribution of the serine kinase c-Jun N-terminal kinase (JNK) to oxidant-induced insulin resistance in isolated rat skeletal muscle

21 January 2018

1 reference

Oxidant stress and skeletal muscle glucose transport: roles of insulin signaling and p38 MAPK.

21 January 2018

1 reference

Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression

21 January 2018

1 reference

Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance.

21 January 2018

1 reference

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

21 January 2018

1 reference

Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats.

21 January 2018

1 reference

Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells

21 January 2018

1 reference

Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat.

21 January 2018

1 reference

Effects of antihypertensive drugs and exercise training on insulin sensitivity in spontaneously hypertensive rats

21 January 2018

1 reference

Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation

21 January 2018

1 reference

Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism

21 January 2018

1 reference

Selective angiotensin II receptor antagonism enhances whole-body insulin sensitivity and muscle glucose transport in hypertensive TG(mREN2)27 rats

21 January 2018

1 reference

Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat.

21 January 2018

1 reference

Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression.

21 January 2018

1 reference

Chronic renin inhibition with aliskiren improves glucose tolerance, insulin sensitivity, and skeletal muscle glucose transport activity in obese Zucker rats

21 January 2018

1 reference

Olmesartan ameliorates insulin sensitivity by modulating tumor necrosis factor-alpha and cyclic AMP in skeletal muscle

21 January 2018

1 reference

Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats

21 January 2018

1 reference

Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice

21 January 2018

1 reference

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

21 January 2018

1 reference

Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats

21 January 2018

1 reference

Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.

21 January 2018

1 reference

Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function.

21 January 2018

1 reference

Angiotensin-converting enzyme 2 activation improves endothelial function

21 January 2018

1 reference

Genetically altered animal models for Mas and angiotensin-(1-7).

21 January 2018

1 reference

Ablation of angiotensin (1-7) receptor Mas in C57Bl/6 mice causes endothelial dysfunction

21 January 2018

1 reference

Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice

21 January 2018

1 reference

Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity

21 January 2018

1 reference

Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.

21 January 2018

1 reference

Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors

21 January 2018

1 reference

Heat shock prevents insulin resistance-induced vascular complications by augmenting angiotensin-(1-7) signaling

21 January 2018

1 reference

Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism

21 January 2018

1 reference

Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.

21 January 2018

1 reference

Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice

21 January 2018

1 reference

The sweeter side of ACE2: physiological evidence for a role in diabetes

21 January 2018

1 reference

Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats

21 January 2018

1 reference

Muscle wasting in cardiac cachexia

21 January 2018

1 reference

Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy

21 January 2018

1 reference

Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept

21 January 2018

1 reference

Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia

21 January 2018

1 reference

Mechanisms of cancer cachexia

21 January 2018

1 reference

Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease

21 January 2018

1 reference

Mechanism of induction of muscle protein degradation by angiotensin II.

21 January 2018

1 reference

Renin-angiotensin system inhibitors protect against age-related changes in rat liver mitochondrial DNA content and gene expression.

21 January 2018

1 reference

Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?

21 January 2018

1 reference

From mitochondria to disease: role of the renin-angiotensin system

21 January 2018

1 reference

Role of renin-angiotensin system in inflammation, immunity and aging.

21 January 2018

1 reference

Angiotensin II revisited: new roles in inflammation, immunology and aging

21 January 2018

1 reference

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting

21 January 2018

1 reference

Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia

21 January 2018

1 reference

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

21 January 2018

1 reference

Ubiquitin and ubiquitin-like proteins as multifunctional signals

21 January 2018

1 reference

Response of the ubiquitin-proteasome pathway to changes in muscle activity

21 January 2018

1 reference

IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression

21 January 2018

1 reference

Insulin-like growth factor I: the yin and yang of muscle atrophy

21 January 2018

1 reference

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

The molecular basis of skeletal muscle atrophy

21 January 2018

1 reference

Reactive oxygen species in skeletal muscle signaling.

21 January 2018

1 reference

Angiotensin II induced catabolic effect and muscle atrophy are redox dependent

21 January 2018

1 reference

Relationship between human aging muscle and oxidative system pathway

21 January 2018

1 reference

Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake. Involvement of ROS in a model of mouse cancer cachexia.

21 January 2018

1 reference

Protein carbonylation and muscle function in COPD and other conditions.

21 January 2018

1 reference

Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis

21 January 2018

1 reference

Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.

21 January 2018

1 reference

p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting

21 January 2018

1 reference

Myonuclear domains in muscle adaptation and disease

21 January 2018

1 reference

Mechanisms of disuse muscle atrophy: role of oxidative stress

21 January 2018

1 reference

Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions

21 January 2018

1 reference

Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle

21 January 2018

1 reference

Regulation of muscle satellite cell activation and chemotaxis by angiotensin II

21 January 2018

1 reference

Disruption of muscle renin-angiotensin system in AT1a-/- mice enhances muscle function despite reducing muscle mass but compromises repair after injury.

21 January 2018

1 reference

Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism

21 January 2018

1 reference

The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice.

21 January 2018

1 reference

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

21 January 2018

1 reference

Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition

21 January 2018

1 reference

Regulation of angiotensin-(1-7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure

21 January 2018

1 reference

Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers.

21 January 2018

1 reference

Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy

21 January 2018

1 reference

Role of proteoglycans in the regulation of the skeletal muscle fibrotic response.

21 January 2018

1 reference

Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis

21 January 2018

1 reference

Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice

21 January 2018

1 reference

Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy(2J) /dy(2J) mouse.

21 January 2018

1 reference

Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A).

21 January 2018

1 reference

The timing of administration of a clinically relevant dose of losartan influences the healing process after contusion induced muscle injury

21 January 2018

1 reference

CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy

21 January 2018

1 reference

Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation

21 January 2018

1 reference

Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy

21 January 2018

1 reference

Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice

21 January 2018

1 reference

Inflammation in muscle repair, aging, and myopathies.

21 January 2018

1 reference

Aberrant repair and fibrosis development in skeletal muscle

21 January 2018

1 reference

Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor

21 January 2018

1 reference

Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases

21 January 2018

1 reference

Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species

21 January 2018

1 reference

Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation

21 January 2018

1 reference

Regulation and dysregulation of fibrosis in skeletal muscle

21 January 2018

1 reference

Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy

21 January 2018

1 reference

Biological approaches to improve skeletal muscle healing after injury and disease

21 January 2018

1 reference

Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle

21 January 2018

1 reference

TGFβ signaling: its role in fibrosis formation and myopathies

21 January 2018

1 reference

Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration

21 January 2018

1 reference

Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events

21 January 2018

1 reference

Stem cell therapies to treat muscular dystrophy: progress to date

21 January 2018

1 reference

Losartan improves adipose tissue-derived stem cell niche by inhibiting transforming growth factor-β and fibrosis in skeletal muscle injury.

21 January 2018

1 reference

Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury.

21 January 2018

1 reference

Angiotensin-(1-7): beyond the cardio-renal actions.

21 January 2018

1 reference

ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production

21 January 2018

1 reference

WITHIN-PATIENT VARIABILITY OF HORMONE AND CYTOKINE CONCENTRATIONS IN HEART FAILURE

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MED.21343

1 reference

2 September 2017

1 reference